Home / Import refusals / AEK-0699448-6/10002/1

FDA Import Refusal AEK-0699448-6/10002/1 — Allergan Pharmaceuticals Ireland

Allergan Pharmaceuticals Ireland — FEI 3002806285

The FDA refused shipment AEK-0699448-6/10002/1 from Allergan Pharmaceuticals Ireland (Ireland) on June 29, 2026. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
June 29, 2026
Country
Ireland
Product Category
Drugs and Biologics
Product Code
58PCZ05 ONABOTULINUMTOXINA
Charges
75

Recent inspections

  • 1194596 (VAI Fri Jun 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1117366 (VAI Fri May 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1002463 (VAI Fri Dec 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 933338 (VAI Fri Jul 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 842267 (NAI Thu Jul 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • SCS-7175957-2/10002/1 (Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-3392795-2/10002/1 (Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-3977889-6/20002/1 (Fri Mar 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-7974795-7/20003/1 (Mon Nov 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-1216897-2/13/1 (Fri Jul 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)

FDA data resources